Skip to the page

Data / Form D filings / Circular Genomics Inc.

Circular Genomics Inc.: Form D filings

Circular Genomics Inc., a biotechnology company in Albuquerque, NM, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on January 23, 2024, reports $8.3 million sold of a $15 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5901 INDIAN SCHOOL RD NE, Albuquerque, NM, 87110
Phone
(505) 357-0792
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1878989

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 23, 2024New notice$15,000,000$8,300,000$6,700,0009Jan 11, 2024sec.gov
Mar 9, 2023Amendment$3,240,000$3,149,997$90,0037Nov 30, 2021sec.gov
Dec 9, 2021New notice$3,240,000$1,549,998$1,690,0024Nov 30, 2021sec.gov
Aug 20, 2021New notice$2,000,000$1,190,000$810,0007Aug 5, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Fortunado RoccaDirector
David BlivinDirector
Paul SargeantExecutive Officer, Director
Waneta TuttleDirector
Nikolaos MelliosDirector
Joseph Cook IIIDirector

Every Form D from the week of Jan 22, 2024 · All recent filings in New Mexico · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Circular Genomics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.